| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Supplement |
1 From the Department of Pediatrics and the Department of Biochemistry and Food Chemistry, the University of Turku, Turku, Finland; and the National Public Health Institute, Turku, Finland.
The gastrointestinal tract functions as a barrier against antigens from microorganisms and food. The generation of immunophysiologic regulation in the gut depends on the establishment of indigenous microflora. This has led to the introduction of novel therapeutic interventions based on the consumption of cultures of beneficial live microorganisms that act as probiotics. Among the possible mechanisms of probiotic therapy is promotion of a nonimmunologic gut defense barrier, which includes the normalization of increased intestinal permeability and altered gut microecology. Another possible mechanism of probiotic therapy is improvement of the intestine's immunologic barrier, particularly through intestinal immunoglobulin A responses and alleviation of intestinal inflammatory responses, which produce a gut-stabilizing effect. Many probiotic effects are mediated through immune regulation, particularly through balance control of proinflammatory and anti-inflammatory cytokines. These data show that probiotics can be used as innovative tools to alleviate intestinal inflammation, normalize gut mucosal dysfunction, and down-regulate hypersensitivity reactions. More recent data show that differences exist in the immunomodulatory effects of candidate probiotic bacteria. Moreover, distinct regulatory effects have been detected in healthy subjects and in patients with inflammatory diseases. These results suggest that specific immunomodulatory properties of probiotic bacteria should be characterized when developing clinical applications for extended target populations.
Key Words: Allergy • gastrointestinal tract • immune response • infants • inflammation • probiotics • antigen • lymphocytes • microflora
This article has been cited by other articles:
|
|
 |
|
  L. Trois, E. M. Cardoso, and E. Miura Use of Probiotics in HIV-infected Children: A Randomized Double-blind Controlled Study J Trop Pediatr, February 1, 2008; 54(1): 19 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Higgins, J. P. Higgins, A. D. Wolfenden, S. N. Henderson, A. Torres-Rodriguez, G. Tellez, and B. Hargis Evaluation of a Lactobacillus-Based Probiotic Culture for the Reduction of Salmonella Enteritidis in Neonatal Broiler Chicks Poult. Sci., January 1, 2008; 87(1): 27 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. L. Willis, O. S. Isikhuemhen, and S. A. Ibrahim Performance Assessment of Broiler Chickens Given Mushroom Extract Alone or in Combination with Probiotics Poult. Sci., September 1, 2007; 86(9): 1856 - 1860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Isakow, L. E. Morrow, and M. H. Kollef Probiotics for Preventing and Treating Nosocomial Infections: Review of Current Evidence and Recommendations Chest, July 1, 2007; 132(1): 286 - 294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Saavedra Use of Probiotics in Pediatrics: Rationale, Mechanisms of Action, and Practical Aspects Nutr Clin Pract, June 1, 2007; 22(3): 351 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Chichlowski, J. Croom, B. W. McBride, L. Daniel, G. Davis, and M. D. Koci Direct-Fed Microbial PrimaLac and Salinomycin Modulate Whole-Body and Intestinal Oxygen Consumption and Intestinal Mucosal Cytokine Production in the Broiler Chick Poult. Sci., June 1, 2007; 86(6): 1100 - 1106. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Galdeano, A. de Moreno de LeBlanc, G. Vinderola, M. E. B. Bonet, and G. Perdigon Proposed Model: Mechanisms of Immunomodulation Induced by Probiotic Bacteria Clin. Vaccine Immunol., May 1, 2007; 14(5): 485 - 492. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Vicente, S. Higgins, L. Bielke, G. Tellez, D. Donoghue, A. Donoghue, and B. Hargis Effect of Probiotic Culture Candidates on Salmonella Prevalence in Commercial Turkey Houses J. Appl. Poult. Res., January 1, 2007; 16(3): 471 - 476. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. V. Emmanuel, A. Jafari, K. A. Beauchemin, J. A. Z. Leedle, and B. N. Ametaj Feeding live cultures of Enterococcus faecium and Saccharomyces cerevisiae induces an inflammatory response in feedlot steers J Anim Sci, January 1, 2007; 85(1): 233 - 239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. R. Haghighi, J. Gong, C. L. Gyles, M. A. Hayes, B. Sanei, P. Parvizi, H. Gisavi, J. R. Chambers, and S. Sharif Modulation of Antibody-Mediated Immune Response by Probiotics in Chickens Clin. Vaccine Immunol., December 1, 2005; 12(12): 1387 - 1392. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. ROVENSKY, K. SVIK, V. MATHA, R. ISTOK, V. KAMARAD, L. EBRINGER, M. FERENCIK, and M. STANCIKOVA Combination Treatment of Rat Adjuvant-Induced Arthritis with Methotrexate, Probiotic Bacteria Enterococcus faecium, and Selenium Ann. N.Y. Acad. Sci., June 1, 2005; 1051(1): 570 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Benyacoub, P. F. Perez, F. Rochat, K. Y. Saudan, G. Reuteler, N. Antille, M. Humen, G. L. De Antoni, C. Cavadini, S. Blum, et al. Enterococcus faecium SF68 Enhances the Immune Response to Giardia intestinalis in Mice J. Nutr., May 1, 2005; 135(5): 1171 - 1176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Salminen, M. Gueimonde, and E. Isolauri Probiotics That Modify Disease Risk J. Nutr., May 1, 2005; 135(5): 1294 - 1298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Humen, G. L. De Antoni, J. Benyacoub, M. E. Costas, M. I. Cardozo, L. Kozubsky, K.-Y. Saudan, A. Boenzli-Bruand, S. Blum, E. J. Schiffrin, et al. Lactobacillus johnsonii La1 Antagonizes Giardia intestinalis In Vivo Infect. Immun., February 1, 2005; 73(2): 1265 - 1269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. W. Van Niel Probiotics: Not Just for Treatment Anymore Pediatrics, January 1, 2005; 115(1): 174 - 177. [Full Text] [PDF]
|
|
|
|
|
|
E. Baharav, F. Mor, M. Halpern, and A. Weinberger Lactobacillus GG Bacteria Ameliorate Arthritis in Lewis Rats J. Nutr., August 1, 2004; 134(8): 1964 - 1969. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Reid, J. Jass, M. T. Sebulsky, and J. K. McCormick Potential Uses of Probiotics in Clinical Practice Clin. Microbiol. Rev., October 1, 2003; 16(4): 658 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Bourlioux, B. Koletzko, F. Guarner, and V. Braesco The intestine and its microflora are partners for the protection of the host: report on the Danone Symposium "The Intelligent Intestine," held in Paris, June 14, 2002 Am. J. Clinical Nutrition, October 1, 2003; 78(4): 675 - 683. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. L. Kettunen, A. S. L. Kettunen, and N. E. Rautonen Intestinal Immune Responses in Wild-Type and ApcMin/+ Mouse, a Model for Colon Cancer Cancer Res., August 15, 2003; 63(16): 5136 - 5142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Krehbiel, S. R. Rust, G. Zhang, and S. E. Gilliland Bacterial direct-fed microbials in ruminant diets: Performance response and mode of action J Anim Sci, February 1, 2003; 81(14_suppl_2): E120 - 132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Ibnou-Zekri, S. Blum, E. J. Schiffrin, and T. von der Weid Divergent Patterns of Colonization and Immune Response Elicited from Two Intestinal Lactobacillus Strains That Display Similar Properties In Vitro Infect. Immun., January 1, 2003; 71(1): 428 - 436. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Bernasconi, J.-E. Germond, M. Delley, R. Fritsche, and B. Corthesy Lactobacillus bulgaricus Proteinase Expressed in Lactococcus lactis Is a Powerful Carrier for Cell Wall-Associated and Secreted Bovine {beta}-Lactoglobulin Fusion Proteins Appl. Envir. Microbiol., June 1, 2002; 68(6): 2917 - 2923. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. BRANDTZAEG Current Understanding of Gastrointestinal Immunoregulation and Its Relation to Food Allergy Ann. N.Y. Acad. Sci., May 1, 2002; 964(1): 13 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Isolauri, P V Kirjavainen, and S Salminen Probiotics: a role in the treatment of intestinal infection and inflammation? Gut, May 1, 2002; 50(90003): iii54 - 59. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kimura, Y. Nagata, C. W. Bryant, and R. K. Buddington Nondigestible Oligosaccharides Do Not Increase Accumulation of Lipid Soluble Environmental Contaminants by Mice J. Nutr., January 1, 2002; 132(1): 80 - 87. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Isolauri Probiotics in human disease Am. J. Clinical Nutrition, June 1, 2001; 73 (6): 1142S - 1146S. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
